The startled crowd broke into applause.
Advertisement
In the same Plains, Georgia, church where he taught a gospel lesson in August just days after announcing cancer had spread to his brain, former President Jimmy Carter gave brighter news to the congregation on Sunday.
In a statement, Carter talked about his ongoing medical plan, “I will continue to receive regular 3-week immunotherapy treatments of pembrolizumab”.
“Metastatic melanoma is a serious and potentially life-threatening illness”. Say hello to Derreck Kayongo, the new CEO of the National Center for Civil and Human Rights. “So that part of it has been a relief to me and I think to the doctors”. I did reach out to Emory directly but they were not able to comment.
But the former peanut farmer built one of the most successful post-White House legacies, winning a Nobel Peace Prize in 2002 and remaining active into his ’90s in causes such as fighting disease in Africa and building homes for the poor.
“President Carter means so much to so many in our Baptist family”, McMahan said.
Immediately, I felt joy and dismay in equal parts.
Carter was first diagnosed in August after a mass was removed from his liver. “They were very small spots, about two millimeters”, he said.
The treatment regimen started with surgically removing the cancerous tumor from the liver, which was followed by radiation treatment. “We don’t know what the future holds for him”.
Last month, the Carter Center said the 39th president was responding well to treatment and that there was no evidence of new growth. “He’s in the best possible place”. And so very likely his immune system got turned on, attacked those cancer cells, eradicated what was there, and hopefully is continuing to eradicate anything we can’t see, and it now recognizes the cancer as something that it needs to get rid of.
“Pembrolizumab is not the only one out there; we have worked for decades on developing drugs to help the immune system”.
Shepard said the recently-approved drug and others like it are important. “That’s awesome progress in a short period of time”.
“The typical new cancer drug coming on the market a decade ago cost about $4,500 per month (in 2012 dollars); since 2010 the median price has been around $10,000”, he wrote in a 2012 op-ed in The New York Times. And that was when drugs were used in most advanced cases.
“There can be fever, diarrhea, malaise (and) appetite issues, but they are usually mild”. And what the Keytruda did is it turned on the immune system to act against those tumors.
Advertisement
Using the immune system as a weapon against cancer makes a lot of sense.
